First Case of Paraphimosis as a Severe Complication of Monkeypox

Eugenio Milano; Alessandra Belati; Laura De Santis; Flavio Tanese; Antonio Vavallo; Giuseppe Dachille; Daniela Loconsole; Davide Fiore Bavaro; Francesco Di Gennaro; Maria Chironna; Pasquale Ditonno; Annalisa Saracino

doi:10.3390/vaccines11010063

First Case of Paraphimosis as a Severe Complication of Monkeypox

Vaccines (Basel). 2022 Dec 28;11(1):63. doi: 10.3390/vaccines11010063.

Affiliations

¹ Clinic of Infectious Diseases, University of Bari, 70124 Bari, Italy.
² Urology, Andrology and Kidney Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.
³ Department of Interdisciplinary Medicine-Hygiene Section, University of Bari, 70124 Bari, Italy.

Abstract

Since May 2022, the monkeypox (MPX) virus has represented an emerging issue due to outbreaks in non-endemic areas. This report presents the first case of paraphimosis caused by an MPX infection during the outbreak. The patient accessed the emergency department for a sudden onset of swelling of the penis and paraphimosis caused by MPX lesions that brought about stenosis of the foreskin. He therefore underwent a dorsal slit procedure with resolution. No antiviral therapy was required. A multidisciplinary approach should be preferred for the management of MPX, due to the possibility of uncommon and disseminated presentations.

Keywords: monkeypox; paraphimosis; unusual presentation.

Publication types

Case Reports

Grants and funding

This research received no external funding.